{"entity":{"type":"insider","cik":"0001627363","url":"/insider/0001627363","json_url":"/insider/0001627363.json","name":"Remeditex Ventures LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2018-01-29","last":"2020-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Remeditex Ventures LLC","source":"filing","n_filings":4,"first_seen":"2018-01-29","last_seen":"2020-07-01"}],"transactions":[{"id":3104289,"accession":"0001548187-20-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001548187-20-000086","line_url":"/filing/0001548187-20-000086#line-1","is_derivative":false,"issuer_cik":"0001548187","issuer_name":"Soliton, Inc.","issuer_ticker":"SOLY","issuer_name_source":null,"issuer_url":"/issuer/0001548187","owner_cik":"0001627363","owner_name":"Remeditex Ventures LLC","owner_display_name":"Remeditex Ventures LLC","owner_url":"/insider/0001627363","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120481.0,"shares_display":"120,481","price_per_share":8.3,"price_display":"8.30","price_state":"stated","total_value":999992.3,"total_display":"999,992.30","total_whole":"999,992","shares_owned_after":9214277.0,"shares_owned_after_display":"9,214,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-01","scope":"insider"},{"id":8226671,"accession":"0001437749-19-020084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-020084","line_url":"/filing/0001437749-19-020084#line-1","is_derivative":false,"issuer_cik":"0001548187","issuer_name":"Soliton, Inc.","issuer_ticker":"SOLY","issuer_name_source":null,"issuer_url":"/issuer/0001548187","owner_cik":"0001627363","owner_name":"Remeditex Ventures LLC","owner_display_name":"Remeditex Ventures LLC","owner_url":"/insider/0001627363","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":155280.0,"shares_display":"155,280","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":9093796.0,"shares_owned_after_display":"9,093,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-11","filed_date":"2019-10-15","scope":"insider"},{"id":8040084,"accession":"0001437749-19-012300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-012300","line_url":"/filing/0001437749-19-012300#line-1","is_derivative":false,"issuer_cik":"0001548187","issuer_name":"Soliton, Inc.","issuer_ticker":"SOLY","issuer_name_source":null,"issuer_url":"/issuer/0001548187","owner_cik":"0001627363","owner_name":"Remeditex Ventures LLC","owner_display_name":"Remeditex Ventures LLC","owner_url":"/insider/0001627363","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357143.0,"shares_display":"357,143","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":8938516.0,"shares_owned_after_display":"8,938,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-19","filed_date":"2019-06-19","scope":"insider"},{"id":6330644,"accession":"0001209191-18-005831","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-005831","line_url":"/filing/0001209191-18-005831#line-1","is_derivative":false,"issuer_cik":"0001566044","issuer_name":"Menlo Therapeutics, Inc.","issuer_ticker":"MNLO","issuer_name_source":null,"issuer_url":"/issuer/0001566044","owner_cik":"0001627363","owner_name":"Remeditex Ventures LLC","owner_display_name":"Remeditex Ventures LLC","owner_url":"/insider/0001627363","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":1700000.0,"total_display":"1,700,000.00","total_whole":"1,700,000","shares_owned_after":1582854.0,"shares_owned_after_display":"1,582,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-25","filed_date":"2018-01-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001548187","name":"Soliton, Inc.","url":"/issuer/0001548187","role":"Ten percent owner","n_filings":3,"first_seen":"2019-06-19","last_seen":"2020-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001566044","name":"Menlo Therapeutics, Inc.","url":"/issuer/0001566044","role":"Ten percent owner","n_filings":1,"first_seen":"2018-01-29","last_seen":"2018-01-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001627363","retrieved_at":"2026-08-25T19:11:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}